© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
May 27, 2021
In this custom video series, Stephen Stahl, MD, PhD, discusses the underlining cause of narcolepsy and the role of the neurotransmitter orexin (hypocretin) in the stabilization of wakefulness.
April 29, 2021
Sedation may not always be desirable, but it is difficult to avoid in psychiatry. Some of the most sedating medications are discussed.
March 29, 2021
Key considerations for healthcare providers seeking to manage their patients’ insomnia.
March 25, 2021
This investigational dual orexin receptor antagonist improved sleep overnight and daytime functioning.
March 18, 2021
The key to better sleep? Stabilizing blood sugar.
March 04, 2021
Nightmare disorder can produce emotional manifestations of fear, anger, and sadness. Here are 7 reasons parasomnias can challenge even the most astute diagnostician.
March 02, 2021
If approved, this formulation of sodium oxybate will be the first once-nightly oxybate treatment for daytime sleepiness.
January 25, 2021
The stress and anxiety of the COVID-19 pandemic might be interfering with sleep patterns.
January 14, 2021
How cost-effective is fully automated digital cognitive behavioral therapy (CBT) intervention for insomnia?
December 03, 2020
The International Project Team Lead for the lemborexant clinical development program shares insights from their presentations at the Virtual SLEEP 2020 Meeting.